Table 1.
Healthy controls (n=8) | RCC patients (n=10) | |
---|---|---|
Number of DCs | nd | 1.7±1.6 |
Phenotype | ||
CD11c+DR+lin− (%) | 93±6 | 64±27 |
CD80+ (%) | 3±2 | 15±26 |
CD86+ (%) | 63±22 | 77±20 |
CD83+ (%) | 1±1 | 3±3 |
DR−lin− (%) | 3±3 | 10±10 |
Healthy controls (n=8) | RCC patients (n=10) | |
---|---|---|
Number of DCs | nd | 1.7±1.6 |
Phenotype | ||
CD11c+DR+lin− (%) | 93±6 | 64±27 |
CD80+ (%) | 3±2 | 15±26 |
CD86+ (%) | 63±22 | 77±20 |
CD83+ (%) | 1±1 | 3±3 |
DR−lin− (%) | 3±3 | 10±10 |